$LTSV
Lightstone Value Plus Reit IV Inc

2024 Q2 Form 10-Q Financial Statement

#000182912624003381 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $8.302M $4.559M $952.9K
YoY Change 16.82% 378.45%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $907.5K $271.1K
YoY Change 234.76%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $2.942M $3.351M $853.9K
YoY Change -8.3% 292.44% 1752.45%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax $8.050K $16.33K $1.138K
% Of Pretax Income
Net Earnings -$1.553M -$3.827M -$2.857M
YoY Change -49.14% 33.96% 460.18%
Net Earnings / Revenue -18.71% -83.95% -299.83%
Basic Earnings Per Share -$0.19 -$0.46 -$0.44
Diluted Earnings Per Share -$0.19 -$0.46 -$0.44
COMMON SHARES
Basic Shares Outstanding 8.300M shares 8.000M shares 8.100M shares
Diluted Shares Outstanding 8.267M shares 8.290M shares 8.375M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $7.321M $4.095M $8.639M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $9.674M $9.628M $12.82M
YoY Change -24.3% -24.9%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $146.5M $141.9M $149.2M
YoY Change 0.26% -4.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $112.1M $105.5M $98.45M
YoY Change 12.92% 7.12%
SHAREHOLDERS EQUITY
Retained Earnings -$44.30M -$42.75M -$30.74M
YoY Change 31.1% 39.07%
Common Stock $82.63K $82.84K $83.66K
YoY Change -0.53% -0.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $24.97M $26.72M $39.54M
YoY Change
Total Liabilities & Shareholders Equity $146.5M $141.9M $149.2M
YoY Change 0.26% -4.93%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$1.553M -$3.827M -$2.857M
YoY Change -49.14% 33.96% 460.18%
Depreciation, Depletion And Amortization $907.5K $271.1K
YoY Change 234.76%
Cash From Operating Activities -$2.158M $2.651M
YoY Change -181.42% -2148.27%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$351.0K -$7.824M
YoY Change -95.51% -28.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$122.5K $8.747M
YoY Change -101.4% -18.18%
NET CHANGE
Cash From Operating Activities -$2.158M $2.651M
Cash From Investing Activities -$351.0K -$7.824M
Cash From Financing Activities -$122.5K $8.747M
Net Change In Cash -$2.632M $3.573M
YoY Change -173.64% -982.91%
FREE CASH FLOW
Cash From Operating Activities -$2.158M $2.651M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q1 us-gaap Pre Opening Costs
PreOpeningCosts
usd
CY2023Q1 us-gaap Noninterest Expense
NoninterestExpense
usd
CY2024Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
usd
CY2023Q1 us-gaap Payments For Loans
PaymentsForLoans
usd
CY2024Q1 lrit Unpaid Interest Accrued And Capitalized As Mortgage Payable And Construction In Progress
UnpaidInterestAccruedAndCapitalizedAsMortgagePayableAndConstructionInProgress
usd
CY2024Q1 lrit Amortization Of Deferred Financing Cost Included In Construction In Progress
AmortizationOfDeferredFinancingCostIncludedInConstructionInProgress
usd
CY2024Q1 us-gaap Leasing Commissions Expense
LeasingCommissionsExpense
usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000.0 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000.0 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000.0 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000.0 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8300000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8300000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8300000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8300000 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
82839 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
83064 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
69383454 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
69607889 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-42749147 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38921944 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
26717146 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
-46070 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
-477134 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-56073 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
30769009 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
9723753 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
10690651 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
36440899 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
41459660 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
141894197 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
145471515 usd
CY2024Q1 us-gaap Revenues
Revenues
4558927 usd
CY2023Q1 us-gaap Revenues
Revenues
952862 usd
CY2024Q1 lrit Hotel Operating Expenses
HotelOperatingExpenses
4632967 usd
CY2023Q1 lrit Hotel Operating Expenses
HotelOperatingExpenses
1339914 usd
CY2024Q1 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
28774 usd
CY2023Q1 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
3520 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
461655 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
256394 usd
CY2023Q1 us-gaap Pre Opening Costs
PreOpeningCosts
1734665 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
907534 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
271098 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
6030930 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
3605591 usd
CY2024Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
33263 usd
CY2023Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
64363 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
3351175 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
853942 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-108507 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-220834 usd
CY2024Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
18304 usd
CY2023Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
1138 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-4916726 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-3664280 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1089523 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-807339 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-3827203 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2856941 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8290062 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8290062 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8374573 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8374573 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
54689531 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-3664280 usd
CY2023Q1 lrit Contributions Of Noncontrolling Interests
ContributionsOfNoncontrollingInterests
56353 usd
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-282538 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
50799066 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
41459660 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-4916726 usd
CY2024Q1 lrit Contributions Of Noncontrolling Interests
ContributionsOfNoncontrollingInterests
122625 usd
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-224660 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
36440899 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-4916726 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-3664280 usd
CY2024Q1 lrit Loss From Investment In Unconsolidated Affiliated Real Estate Entity
LossFromInvestmentInUnconsolidatedAffiliatedRealEstateEntity
-108507 usd
CY2023Q1 lrit Loss From Investment In Unconsolidated Affiliated Real Estate Entity
LossFromInvestmentInUnconsolidatedAffiliatedRealEstateEntity
-220834 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
907534 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
271098 usd
CY2024Q1 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
225664 usd
CY2023Q1 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
119891 usd
CY2024Q1 us-gaap Noninterest Expense
NoninterestExpense
1480436 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5179888 usd
CY2024Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
46483 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
46098 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2158105 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2650663 usd
CY2024Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
350959 usd
CY2023Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
7782803 usd
CY2023Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
41666 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-350959 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7824469 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
95056 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
8973465 usd
CY2024Q1 us-gaap Payments For Loans
PaymentsForLoans
115500 usd
CY2024Q1 lrit Contributions Of Noncontrolling Interest
ContributionsOfNoncontrollingInterest
122625 usd
CY2023Q1 lrit Contributions Of Noncontrolling Interest
ContributionsOfNoncontrollingInterest
56353 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
224660 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
282538 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-122479 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8747280 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2631543 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3573474 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7731819 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9504594 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5100276 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13078068 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
16333 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1138 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
1598316 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
1289391 usd
CY2024Q1 lrit Capital Expenditures For Investment Property In Accounts Payable Accrued Expenses And Other Liabilities
CapitalExpendituresForInvestmentPropertyInAccountsPayableAccruedExpensesAndOtherLiabilities
35385 usd
CY2023Q1 lrit Capital Expenditures For Investment Property In Accounts Payable Accrued Expenses And Other Liabilities
CapitalExpendituresForInvestmentPropertyInAccountsPayableAccruedExpensesAndOtherLiabilities
3487630 usd
CY2023Q1 lrit Unpaid Interest Accrued And Capitalized As Mortgage Payable And Construction In Progress
UnpaidInterestAccruedAndCapitalizedAsMortgagePayableAndConstructionInProgress
1060366 usd
CY2023Q1 lrit Amortization Of Deferred Financing Cost Included In Construction In Progress
AmortizationOfDeferredFinancingCostIncludedInConstructionInProgress
326103 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4094932 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8639109 usd
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
1005344 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
4438959 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
5100276 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
13078068 usd
CY2024Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2014-09-09
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 integer
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16333 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1138 usd
CY2024Q1 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2023Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_z7Ok0P54nErk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b><i><span id="xdx_862_zbm3e9S0bRx4">Concentration of Risk</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">As of March 31, 2024 and December 31, 2023, the Company had cash deposited in certain financial institutions in excess of U.S. federally insured levels. The Company regularly monitors the financial stability of these financial institutions and believes that it is not exposed to any significant credit risk with respect to its cash and cash equivalents or restricted cash.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"> </p>
CY2024Q1 us-gaap Construction Loan
ConstructionLoan
85400000 usd
CY2024Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
8400000 usd
CY2024Q1 lrit Deferred Financing Fees
DeferredFinancingFees
38500 usd
CY2023Q4 us-gaap Construction Loan
ConstructionLoan
83800000 usd
CY2023 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
6900000 usd
CY2023 lrit Deferred Financing Fees
DeferredFinancingFees
148665000 usd
CY2024Q1 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.1443 pure
CY2024Q1 us-gaap Loan Processing Fee
LoanProcessingFee
3700000 usd
CY2024Q1 lrit Accrued Loan Exit Fees
AccruedLoanExitFees
800000 usd
CY2024Q1 lrit Repurchasement Of Common Shares
RepurchasementOfCommonShares
22466 shares
CY2024Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.00
CY2023Q1 lrit Repurchasement Of Common Shares
RepurchasementOfCommonShares
32929 shares
CY2023Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
8.58
CY2023Q1 us-gaap Leasing Commissions Expense
LeasingCommissionsExpense
286042 usd
CY2024Q1 us-gaap Management Fee Expense
ManagementFeeExpense
243154 usd
CY2023Q1 us-gaap Management Fee Expense
ManagementFeeExpense
60257 usd
CY2024Q1 lrit Total
Total
243154 usd
CY2023Q1 lrit Total
Total
346299 usd
CY2024Q1 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
372306 usd
CY2023Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
463876 usd
CY2016Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10.00
CY2016Q1 lrit Net Investment Annual Return
NetInvestmentAnnualReturn
0.080 pure
CY2016Q1 lrit Additional Cummulative Net Investment Rate
AdditionalCummulativeNetInvestmentRate
0.080 pure
CY2016Q1 lrit Additional Distributions Rate
AdditionalDistributionsRate
0.850 pure
CY2016Q1 lrit Aggregate Amount Rate
AggregateAmountRate
0.150 pure
CY2016Q1 lrit Pretax Noncompounded Annual Return
PretaxNoncompoundedAnnualReturn
0.080 pure
CY2024Q1 lrit Unamortized Balance
UnamortizedBalance
2900000 usd

Files In Submission

Name View Source Status
0001829126-24-003381-index-headers.html Edgar Link pending
0001829126-24-003381-index.html Edgar Link pending
0001829126-24-003381.txt Edgar Link pending
0001829126-24-003381-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lightstonereit4_10q.htm Edgar Link pending
lightstonereit4_ex31-1.htm Edgar Link pending
lightstonereit4_ex31-2.htm Edgar Link pending
lightstonereit4_ex32-1.htm Edgar Link pending
lightstonereit4_ex32-2.htm Edgar Link pending
lrit-20240331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
lrit-20240331_cal.xml Edgar Link unprocessable
lrit-20240331_def.xml Edgar Link unprocessable
lrit-20240331_lab.xml Edgar Link unprocessable
lrit-20240331_pre.xml Edgar Link unprocessable
lightstonereit4_10q_htm.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable